Bryn Mawr, PA, United States of America

Younghoon Oh

This inventor holds 1 USPTO granted patent and 1 published patent application and 2 EPO patents. Top assignee: Spark Therapeutics, Inc.. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Younghoon Oh. Retrieved from https://idiyas.com/inventor/younghoon-oh-9ndb9gpk

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Mind of Younghoon Oh

Introduction

Younghoon Oh, an accomplished inventor based in Bryn Mawr, PA, holds a notable patent that contributes to advancements in biotechnology. His work primarily revolves around improving the manufacturing process of recombinant adeno-associated (rAAV) vector particles, which are crucial in gene therapy applications.

Latest Patents

Younghoon Oh's significant patent is titled "Column-based fully scalable rAAV manufacturing process." This innovative method provides effective techniques for purifying rAAV vector particles, enhancing efficiency in the production process and ultimately supporting therapeutic developments.

Career Highlights

Younghoon Oh is currently employed by Spark Therapeutics, Inc., a leading genetic therapies company. His expertise in biotechnology and his unique contributions to the field have positioned him as a valuable asset to the organization.

Collaborations

Throughout his career, Younghoon Oh has collaborated with notable professionals in his field, including Guang Qu and Lin Lu. These partnerships have allowed for a synergistic approach to innovation, leading to significant advancements in rAAV manufacturing methods.

Conclusion

Younghoon Oh exemplifies the spirit of innovation in the biotechnology sector. His ongoing contributions to the development of scalable rAAV manufacturing processes reflect his commitment to advancing gene therapy, making a lasting impact in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…